news FDA scraps AdComm for Reata's rare disease candidate – FierceBiotech alex mun October 17, 2022 1 min read FDA scraps AdComm for Reata’s rare disease candidate FierceBiotechsource Chat read-only to anonymous users. Chat with Anyone and Anywhere. Only registered users are allowed to send messages. Loading the chat ... 26871 Register Login Continue Reading Previous: AstraZeneca links climate change and human health in new corporate 'Science Can' campaign – Endpoints NewsNext: Asian aunties go from asking about your love life to a Netflix movie – South China Morning Post Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ